Sotirios Parashos is a Neurology physician affiliated with Park Nicollet Health Services. OpenAlex indexes 70 publications with 2,760 citations (h-index 28); ClinicalTrials.gov lists 2 registered studies matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
3931 Louisiana Ave S
St Louis Park, MN 554265000
Telephone
952-993-3230Provider last certified this registry record 26 May 2022.
Clinical trials
- Safety and Efficacy of DA-9805 for Parkinson's Disease
Sponsor: Dong-A ST Co., Ltd.
- Mirabegron in Parkinson Disease and Impaired Cognition
Sponsor: HealthPartners Institute
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
2 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Medtronic, Inc.Program year20231 payment
- AbbVie Inc.Program year20211 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Musculoskeletal
57.3%Neuromuscular Blocker57%Onabotulinumtoxina100%Part B, office-administered≥11 patientsgamma-Aminobutyric Acid-ergic Agonist0.2%Baclofen100%Part D<11 patients+ 1 more class in this area
Nervous system
41%Aromatic Amino Acid Decarboxylation Inhibitor21.9%Carbidopa-Levodopa62%Carbidopa-Levodopa Er24%Rytary13%Carbidopa-Levodopa-Entacapone1%Carbidopa1%Part D<11 patientsCholinesterase Inhibitor5.3%Donepezil Hcl86%Rivastigmine11%Galantamine Hbr3%Part D<11 patients+ 16 more classes in this area
Cardiovascular
1%alpha-Adrenergic Agonist0.5%Midodrine Hcl100%Part D≥12 patientsBeta blocker0.5%Propranolol Hcl74%Propranolol Hcl Er26%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Hip Fracture Care in Parkinson Disease: A Retrospective Analysis of 1,239 Patients
Geriatric Orthopaedic Surgery & Rehabilitation
2022 - Integrated Care in Parkinson's Disease: A Systematic Review and <scp>Meta‐Analysis</scp>
Movement Disorders
2020
Similar KOLs
Other experts from the same institution or the same specialty.
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”